Portfolio Value: $11,491
Weekly Change: +2.76%
YTD Return: +11.14%
Options Premium Collected: $68
As of April 3, 2026, the options income portfolio increased by 2.76%, closing the week at $11,491.
The trading week was shortened ahead of Easter, while market sentiment remained heavily influenced by developments surrounding the conflict involving Iran. Energy prices, geopolitical uncertainty, and currency fluctuations continued to contribute to market volatility.
Because the portfolio is measured in euros, it briefly moved above the €10,000 level several times during the week before finishing slightly below that threshold.
On a year-to-date basis, the portfolio is up 11.14%, outperforming both the S&P 500, down 4.16%, and NVIDIA, down 6.74%, over the same period.
NVDA Recovery Supports Portfolio Growth
NVIDIA recovered above the $170 level during the week, helping support the overall portfolio value.
The portfolio remains heavily concentrated in NVDA, which continues to serve as the main source of both capital appreciation and options income.
Concentration risk remains something to monitor closely. At the same time, NVDA's liquidity and active options market continue to make it a practical underlying asset for recurring premium-selling strategies.
Current Options Positions
- NVDA Apr 10, 2026 165/157.5 Bull Put Credit Spread
- 2x BMY Jun 18, 2026 50/46 Bull Put Credit Spread
- PFE May 15, 2026 25 Cash-Secured Put
- NVDA Nov 20, 2026 $120 Covered Call
Most of the portfolio's short-term premium continues to come from NVDA credit spreads, while the Pfizer position serves as a longer-term cash-secured put trade.
Growing a Dividend Position With Options Income
One topic I spent time considering this week was dividend income.
Because the portfolio remains relatively small and concentrated in growth-oriented positions, the current dividend stream is modest.
I briefly considered adding energy stocks to increase dividend income. After reviewing several candidates, however, I decided against introducing new positions solely for yield.
Instead, I chose to continue building the existing Pfizer position.
The plan remains straightforward:
- Gradually accumulate shares
- Use options premium to help fund purchases
- Allow dividend income to grow organically over time
Rather than chasing unusually high yields, I prefer building positions gradually and consistently.
During the week, premium generated from NVDA credit spreads was used to purchase:
- 0.1 shares of NVDA
- 0.5 shares of PFE
This reflects one of the core principles behind the portfolio: options premium is used not only to generate immediate cash flow but also to support long-term portfolio growth.
Why I Continue Using Credit Spreads
As the portfolio evolves, I increasingly appreciate the capital efficiency of bull put credit spreads.
Compared with cash-secured puts, credit spreads allow me to define the maximum risk while requiring substantially less capital.
That flexibility is particularly valuable in a smaller portfolio where buying power must be balanced between income generation, risk control, and diversification.
The trade-off is that credit spreads can be less flexible than cash-secured puts when the underlying stock moves sharply against the position. Because of this, position sizing and active management remain important.
Weekly Premium Income and Margin Debt
This week generated approximately $68 in options premium.
A major portfolio objective remains reducing margin debt while maintaining a core holding of at least 100 NVDA shares.
Current margin debt stands at approximately -$3,474.
At a sustained pace of $68 per week, it would theoretically take around 51 weeks to eliminate the current margin balance.
In practice, options income is unlikely to remain constant. Weekly premiums fluctuate, positions may require adjustment, and market conditions can either create or remove opportunities.
The long-term goal remains unchanged: reduce and ideally eliminate margin debt without selling the core portfolio positions.
Whether that happens during 2026 or later is less important than maintaining disciplined risk management throughout the process.
Looking Ahead
The primary position to monitor next week is:
- NVDA Apr 10, 2026 165/157.5 Bull Put Credit Spread
If the position comes under pressure, the plan remains unchanged:
- Roll forward when appropriate
- Prefer collecting additional credit
- Prioritize long-term portfolio stability
The objective is not to defend every trade indefinitely. It is to manage risk, preserve capital, and avoid emotional decisions when volatility increases.
Key Takeaway
This week reinforced an important investing principle: portfolio growth does not always require finding new opportunities.
Sometimes the better decision is to continue building existing positions, reinvest premium income, and allow compounding to work over time.
Rather than chasing higher yields or introducing unnecessary complexity, I chose to strengthen positions already held in the portfolio and continue building both income and ownership gradually.
Disclaimer
This trade journal reflects personal portfolio activity and is provided for educational and informational purposes only. It should not be considered investment advice, financial advice, tax advice, or a recommendation to buy or sell any security, option, derivative, or financial instrument. Options trading involves risk and may not be suitable for all investors. All investments involve the possible loss of principal.